TY - JOUR
T1 - Novel vaccine strategies against emerging viruses
AU - García-Sastre, Adolfo
AU - Mena, Ignacio
N1 - Funding Information:
We would like to thank Florian Krammer for providing the hemagglutinin image ( Figure 1 ) and Randy Albrecht for critically reading the manuscript. Work at the A.G.-S. laboratory is partially funded by the CEIRS program of the National Institute of Allergy and Infectious Diseases, National Institute of Health , under contract number HHSN266200700010C.
PY - 2013/4
Y1 - 2013/4
N2 - One of the main public health concerns of emerging viruses is their potential introduction into and sustained circulation among populations of immunologically naïve, susceptible hosts. The induction of protective immunity through vaccination can be a powerful tool to prevent this concern by conferring protection to the population at risk. Conventional approaches to develop vaccines against emerging pathogens have significant limitations: lack of experimental tools for several emerging viruses of concern, poor immunogenicity, safety issues, or lack of cross-protection against antigenic variants. The unpredictability of the emergence of future virus threats demands the capability to rapidly develop safe, effective vaccines.We describe some recent advances in new vaccine strategies that are being explored as alternatives to classical attenuated and inactivated vaccines, and provide examples of potential novel vaccines for emerging viruses. These approaches might be applied to the control of many other emerging pathogens.
AB - One of the main public health concerns of emerging viruses is their potential introduction into and sustained circulation among populations of immunologically naïve, susceptible hosts. The induction of protective immunity through vaccination can be a powerful tool to prevent this concern by conferring protection to the population at risk. Conventional approaches to develop vaccines against emerging pathogens have significant limitations: lack of experimental tools for several emerging viruses of concern, poor immunogenicity, safety issues, or lack of cross-protection against antigenic variants. The unpredictability of the emergence of future virus threats demands the capability to rapidly develop safe, effective vaccines.We describe some recent advances in new vaccine strategies that are being explored as alternatives to classical attenuated and inactivated vaccines, and provide examples of potential novel vaccines for emerging viruses. These approaches might be applied to the control of many other emerging pathogens.
UR - http://www.scopus.com/inward/record.url?scp=84880075363&partnerID=8YFLogxK
U2 - 10.1016/j.coviro.2013.02.001
DO - 10.1016/j.coviro.2013.02.001
M3 - Review article
AN - SCOPUS:84880075363
SN - 1879-6257
VL - 3
SP - 210
EP - 216
JO - Current Opinion in Virology
JF - Current Opinion in Virology
IS - 2
ER -